undefined

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

Year of publication

2020

Authors

Agache, Ioana; Beltran, Jessica; Akdis, Cezmi; Akdis, Mubeccel; Canelo-Aybar, Carlos; Canonica, Walter; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; Del Giacco, Stefano; Eiwegger, Thomas; Firinu, Davide; Gern, James E.; Hamelmann, Eckard; Hanania, Nicola; Mäkelä, Mika; Martín, Irene Hernández; Nair, Parameswaran; O’Mahony, Liam; Papadopoulos, Nikolaos G.
Show more

Organizations and authors

University of Helsinki

Mäkelä Mika

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Allergy

Volume

75

Issue

5

Pages

1023-1042

​Publication forum

50774

​Publication forum level

2

Open access

Open access in the publisher’s service

No

Open access of publication channel

Partially open publication channel

Self-archived

Yes

Other information

Fields of science

Biomedicine; General medicine, internal medicine and other clinical medicine

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United Kingdom

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

No

DOI

10.1111/all.14221

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes